Orion Pharma Limited (DSE:ORIONPHARM)

Orion Pharma Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 3, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	9,500	16,169	18,626	20,592	12,613	9,828
Market Cap Growth	-54.84%	-13.19%	-9.54%	63.27%	28.33%	26.51%
Enterprise Value	34,575	39,765	42,351	40,514	28,904	23,780
Last Close Price	40.60	67.36	76.63	83.74	50.68	38.57
PE Ratio	-	50.83	29.06	24.34	13.43	14.76
PS Ratio	1.53	1.52	1.34	2.13	1.16	1.29
PB Ratio	0.42	0.70	0.83	0.99	0.63	0.51
P/TBV Ratio	0.46	0.75	0.89	1.07	0.68	0.55
P/FCF Ratio	192.96	-	-	-	-	29.00
P/OCF Ratio	4.53	10.19	7.47	17.73	4.87	5.22
EV/Sales Ratio	5.58	3.74	3.04	4.19	2.67	3.11
EV/EBITDA Ratio	28.54	26.51	26.91	35.29	11.43	9.66
EV/EBIT Ratio	60.57	42.80	42.65	60.01	18.79	15.32
EV/FCF Ratio	702.23	-	-	-	-	70.17
Debt / Equity Ratio	1.06	0.98	0.98	0.90	0.84	0.72
Debt / EBITDA Ratio	19.73	14.83	13.74	15.87	6.59	5.51
Debt / FCF Ratio	482.00	-	-	-	-	40.50
Asset Turnover	0.12	0.20	0.28	0.21	0.27	0.23
Inventory Turnover	2.62	5.04	7.12	5.01	6.10	4.62
Quick Ratio	1.69	1.82	1.64	1.59	2.14	2.86
Current Ratio	1.99	2.17	2.01	1.99	2.70	3.99
Return on Equity (ROE)	-0.63%	1.55%	3.22%	4.36%	5.73%	3.89%
Return on Assets (ROA)	0.66%	1.09%	1.23%	0.93%	2.43%	2.86%
Return on Capital (ROIC)	0.77%	1.29%	1.48%	1.11%	2.75%	3.21%
Return on Capital Employed (ROCE)	1.20%	2.00%	2.30%	1.70%	4.20%	4.80%
Earnings Yield	-1.15%	1.97%	3.44%	4.11%	7.45%	6.77%
FCF Yield	0.52%	-1.79%	-7.33%	-7.31%	-13.36%	3.45%
Dividend Yield	2.46%	1.48%	1.31%	1.19%	2.37%	2.59%
Payout Ratio	-	84.84%	23.86%	38.36%	36.22%	56.04%
Total Shareholder Return	2.46%	1.48%	1.31%	1.19%	2.37%	2.59%

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.